🇺🇸 FDA
Patent

US 8252814

Agents and crystals for improving excretory potency of urinary bladder

granted A61KA61K31/00A61K31/343

Quick answer

US patent 8252814 (Agents and crystals for improving excretory potency of urinary bladder) held by Takeda Pharmaceutical Company Limited expires Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Aug 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K31/00, A61K31/343, A61K31/382, A61K31/395